Literature DB >> 22960311

Morphological and genetic activation of microglia after diffuse traumatic brain injury in the rat.

T Cao1, T C Thomas, J M Ziebell, J R Pauly, J Lifshitz.   

Abstract

Traumatic brain injury (TBI) survivors experience long-term post-traumatic morbidities. In diffuse brain-injured rats, a chronic sensory sensitivity to whisker stimulation models the agitation of TBI survivors and provides anatomical landmarks across the whisker-barrel circuit to evaluate post-traumatic neuropathology. As a consequence of TBI, acute and chronic microglial activation can contribute to degenerative and reparative events underlying post-traumatic morbidity. Here we hypothesize that a temporal sequence of microglial activation states contributes to the circuit pathology responsible for post-traumatic morbidity, and test the hypothesis by examining microglial morphological activation and neuroinflammatory markers for activation states through gene expression and receptor-binding affinity. Adult male, Sprague-Dawley rats were subjected to a single moderate midline fluid percussion injury (FPI) or sham injury. Microglial activation was determined by immunohistochemistry, quantitative real-time PCR and receptor autoradiography in the primary somatosensory barrel field (S1BF) and ventral posterior medial nucleus (VPM) of the thalamus at 7 and 28 days following FPI. Morphological changes indicative of microglial activation, including swollen cell body with thicker, shrunken processes, were evident in S1BF and VPM at 7 and 28 days post-injury. Principally at 7 days post-injury in VPM, general inflammatory gene expression (major histocompatibility complex I, major histocompatibility complex II, translocator protein 18 kDa [TSPO]) is increased above sham level and TSPO gene expression confirmed by receptor autoradiography. Further, CD45, a marker of classical activation, and TGF-βI, an acquired deactivation marker, were elevated significantly above sham at 7 days post-injury. Daily administration of the anti-inflammatory ibuprofen (20mg/kg, i.p.) significantly reduced the expression of these genes. Evidence for alternative activation (arginase 1) was not observed. Thus, these data demonstrate concomitant classical activation and acquired deactivation phenotypes of microglia in diffuse TBI in the absence of overt contusion or cavitation. Anti-inflammatory treatment may further alleviate the neuropathological burden of post-traumatic inflammation.
Copyright © 2012 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22960311      PMCID: PMC3489473          DOI: 10.1016/j.neuroscience.2012.08.058

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  69 in total

1.  Neuroinflammatory responses after experimental diffuse traumatic brain injury.

Authors:  Brian Joseph Kelley; Jonathan Lifshitz; John Theodore Povlishock
Journal:  J Neuropathol Exp Neurol       Date:  2007-11       Impact factor: 3.685

Review 2.  Can the immune system be harnessed to repair the CNS?

Authors:  Phillip G Popovich; Erin E Longbrake
Journal:  Nat Rev Neurosci       Date:  2008-06       Impact factor: 34.870

Review 3.  The nature, distribution and causes of traumatic brain injury.

Authors:  D I Graham; J H Adams; J A Nicoll; W L Maxwell; T A Gennarelli
Journal:  Brain Pathol       Date:  1995-10       Impact factor: 6.508

4.  Attenuated neurological deficit, cell death and lesion volume in Fas-mutant mice is associated with altered neuroinflammation following traumatic brain injury.

Authors:  Jenna M Ziebell; Nicole Bye; Bridgette D Semple; Thomas Kossmann; Maria Cristina Morganti-Kossmann
Journal:  Brain Res       Date:  2011-08-02       Impact factor: 3.252

Review 5.  Microglial activation and matrix protease generation during focal cerebral ischemia.

Authors:  Gregory J del Zoppo; Richard Milner; Takuma Mabuchi; Stephanie Hung; Xiaoyun Wang; Greta I Berg; James A Koziol
Journal:  Stroke       Date:  2007-02       Impact factor: 7.914

6.  Ibuprofen enhances recovery from spinal cord injury by limiting tissue loss and stimulating axonal growth.

Authors:  Xingxing Wang; Stephane Budel; Kenneth Baughman; Grahame Gould; Kang-Ho Song; Stephen M Strittmatter
Journal:  J Neurotrauma       Date:  2009-01       Impact factor: 5.269

7.  Alterations in BDNF and synapsin I within the occipital cortex and hippocampus after mild traumatic brain injury in the developing rat: reflections of injury-induced neuroplasticity.

Authors:  Grace Sophia Griesbach; David Allen Hovda; Raffaella Molteni; Fernando Gomez-Pinilla
Journal:  J Neurotrauma       Date:  2002-07       Impact factor: 5.269

Review 8.  Modulation of immune response by head injury.

Authors:  Maria Cristina Morganti-Kossmann; Laveniya Satgunaseelan; Nicole Bye; Thomas Kossmann
Journal:  Injury       Date:  2007-11-28       Impact factor: 2.586

9.  Influence of stochastic gene expression on the cell survival rheostat after traumatic brain injury.

Authors:  Daniel R Rojo; Donald S Prough; Michael T Falduto; Deborah R Boone; Maria-Adelaide Micci; Kristen M Kahrig; Jeanna M Crookshanks; Arnaldo Jimenez; Tatsuo Uchida; Jeremy C Cowart; Bridget E Hawkins; Marcela Avila; Douglas S DeWitt; Helen L Hellmich
Journal:  PLoS One       Date:  2011-08-11       Impact factor: 3.240

10.  Effects of genetic deficiency of cyclooxygenase-1 or cyclooxygenase-2 on functional and histological outcomes following traumatic brain injury in mice.

Authors:  Matthew L Kelso; Stephen W Scheff; James R Pauly; Charles D Loftin
Journal:  BMC Neurosci       Date:  2009-08-31       Impact factor: 3.288

View more
  84 in total

1.  Sequential activation of microglia and astrocyte cytokine expression precedes increased Iba-1 or GFAP immunoreactivity following systemic immune challenge.

Authors:  Diana M Norden; Paige J Trojanowski; Emmanuel Villanueva; Elisa Navarro; Jonathan P Godbout
Journal:  Glia       Date:  2015-10-15       Impact factor: 7.452

Review 2.  Bridge between neuroimmunity and traumatic brain injury.

Authors:  Matthew L Kelso; Howard E Gendelman
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

3.  Acute Post-Traumatic Sleep May Define Vulnerability to a Second Traumatic Brain Injury in Mice.

Authors:  Rachel K Rowe; Jordan L Harrison; Helena W Morrison; Vignesh Subbian; Sean M Murphy; Jonathan Lifshitz
Journal:  J Neurotrauma       Date:  2018-12-18       Impact factor: 5.269

4.  Does time heal all wounds? Experimental diffuse traumatic brain injury results in persisting histopathology in the thalamus.

Authors:  Theresa Currier Thomas; Sarah B Ogle; Benjamin M Rumney; Hazel G May; P David Adelson; Jonathan Lifshitz
Journal:  Behav Brain Res       Date:  2016-12-29       Impact factor: 3.332

5.  Phage display for identification of serum biomarkers of traumatic brain injury.

Authors:  Sarbani Ghoshal; Vimala Bondada; Kathryn E Saatman; Rodney P Guttmann; James W Geddes
Journal:  J Neurosci Methods       Date:  2016-05-07       Impact factor: 2.390

6.  Acute over-the-counter pharmacological intervention does not adversely affect behavioral outcome following diffuse traumatic brain injury in the mouse.

Authors:  Jordan L Harrison; Rachel K Rowe; Bruce F O'Hara; P David Adelson; Jonathan Lifshitz
Journal:  Exp Brain Res       Date:  2014-04-24       Impact factor: 1.972

7.  Incretin Mimetics as Rational Candidates for the Treatment of Traumatic Brain Injury.

Authors:  Elliot J Glotfelty; Thomas Delgado; Luis B Tovar-Y-Romo; Yu Luo; Barry Hoffer; Lars Olson; Tobias Karlsson; Mark P Mattson; Brandon Harvey; David Tweedie; Yazhou Li; Nigel H Greig
Journal:  ACS Pharmacol Transl Sci       Date:  2019-02-11

8.  Nogo presence is inversely associated with shifts in cortical microglial morphology following experimental diffuse brain injury.

Authors:  Jenna M Ziebell; Helen Ray-Jones; Jonathan Lifshitz
Journal:  Neuroscience       Date:  2017-07-20       Impact factor: 3.590

9.  Treatment of traumatic brain injury in rats with N-acetyl-seryl-aspartyl-lysyl-proline.

Authors:  Yanlu Zhang; Zheng Gang Zhang; Michael Chopp; Yuling Meng; Li Zhang; Asim Mahmood; Ye Xiong
Journal:  J Neurosurg       Date:  2016-05-20       Impact factor: 5.115

Review 10.  Animal models of traumatic brain injury.

Authors:  Ye Xiong; Asim Mahmood; Michael Chopp
Journal:  Nat Rev Neurosci       Date:  2013-02       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.